163 related articles for article (PubMed ID: 37495565)
1. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic.
Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D
Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center.
Duan GY; Ruiz de Luzuriaga AM
Arch Dermatol Res; 2023 Apr; 315(3):643-645. PubMed ID: 36149480
[TBL] [Abstract][Full Text] [Related]
3. Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.
Moreno-Ramírez D; Duarte-Ferreras MA; Ojeda-Vila T; García-Morales I; Conejo-Mir MD; Fernández-Orland A; Sánchez-Del-Campo AI; Eiris N; Carrizosa AM; Ruiz-de-Casas A; de-la-Torre JM; Herrerías-Esteban JM; Ferrándiz L
J Am Acad Dermatol; 2022 Nov; 87(5):1186-1189. PubMed ID: 35271937
[No Abstract] [Full Text] [Related]
4. Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospital.
Demirel Öğüt N; Kutlu Ö; Erbağcı E
J Cosmet Dermatol; 2021 Jul; 20(7):1969-1974. PubMed ID: 33884755
[TBL] [Abstract][Full Text] [Related]
5. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
Lee G; Wolf JR; Somers KE
Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224
[TBL] [Abstract][Full Text] [Related]
6. The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.
Shah N; Kirkorian AY
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():183-184. PubMed ID: 34184311
[No Abstract] [Full Text] [Related]
7. Racial, ethnic, and biologic sex disparities in outpatient laboratory monitoring of isotretinoin use: a cross-sectional study.
Manoharan D; Nkansah-Mahaney N; Chien A
Int J Dermatol; 2024 Apr; 63(4):481-483. PubMed ID: 38108599
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
Owens KE; Jiang SW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
[TBL] [Abstract][Full Text] [Related]
9. Removal of Isotretinoin Gender-Based Guidelines: Inclusivity Takes Precedence.
Nanda S
Cutis; 2022 Mar; 109(3):E18-E20. PubMed ID: 35659135
[TBL] [Abstract][Full Text] [Related]
10. Prescribing isotretinoin for transgender youth: A pledge for more inclusive care.
Boos MD; Ginsberg BA; Peebles JK
Pediatr Dermatol; 2019 Jan; 36(1):169-171. PubMed ID: 30318854
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the changes in sebum, moisturization and elasticity in acne vulgaris patients receiving systemic isotretinoin treatment.
Gencebay G; Aşkın Ö; Serdaroğlu S
Cutan Ocul Toxicol; 2021 Jun; 40(2):140-144. PubMed ID: 33978534
[TBL] [Abstract][Full Text] [Related]
12. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
Öktem A; Hayran Y; Arı E; Yalçın B
J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
[No Abstract] [Full Text] [Related]
13. Single-institution retrospective review evaluating the impact of the Covid-19 pandemic on isotretinoin prescribing practices.
Poplausky D; Block BR; Chang A; Thakker S; Young JN; Gulati N; Ungar J
J Dermatolog Treat; 2024 Dec; 35(1):2291326. PubMed ID: 38102844
[No Abstract] [Full Text] [Related]
14. Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients.
Shah N; Smith E; Kirkorian AY
J Am Acad Dermatol; 2021 Dec; 85(6):1597-1599. PubMed ID: 33259877
[No Abstract] [Full Text] [Related]
15. Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States?
Fleischer AB; Simpson JK; McMichael A; Feldman SR
J Am Acad Dermatol; 2003 Oct; 49(4):662-6. PubMed ID: 14512913
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
J Am Acad Dermatol; 2020 Jan; 82(1):72-79. PubMed ID: 31228528
[TBL] [Abstract][Full Text] [Related]
17. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment.
Secrest AM; Hopkins ZH; Frost ZE; Taliercio VL; Edwards LD; Biber JE; Chen SC; Chren MM; Ferris LK; Kean J; Hess R;
JAMA Dermatol; 2020 Oct; 156(10):1098-1106. PubMed ID: 32639529
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
[TBL] [Abstract][Full Text] [Related]
20. [Second joint position paper: Use of isotretinoin in severe acne].
Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
